| Stage | TMHC | % of rev | DHI | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.4B | 100.00% | $9.2B | 100.00% | DHI ×6.65 |
| Gross profit | $291M | 20.95% | $2.1B | 23.26% | DHI +2.3pp |
| Operating income | $142M | 10.22% | $1.2B | 12.52% | DHI +2.3pp |
| Pre-tax income | $131M | 9.42% | $1.2B | 13.29% | DHI +3.9pp |
| Net income | $100M | 7.24% | $919M | 9.96% | DHI +2.7pp |
| Stage | TMHC | DHI | Gap · A − B |
|---|---|---|---|
| Revenue | $1.4B100.00% | $9.2B100.00% | DHI ×6.65 |
| Gross profit | 20.95%$291M | 23.26%$2.1B | DHI +2.3pp |
| Operating income | 10.22%$142M | 12.52%$1.2B | DHI +2.3pp |
| Pre-tax income | 9.42%$131M | 13.29%$1.2B | DHI +3.9pp |
| Net income |
| 7.24%$100M |
| 9.96%$919M |
| DHI +2.7pp |
None
TMHC · PCYO 10-KNov 12 '25
“Taylor Morrison 8 % - %”
DHI · PCYO 10-KNov 12 '25
“Melody (DR Horton) 30 % 19 %”